Stock 08HH SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Deutsche Boerse AG

Equities

08HH

CNE100001M79

Market Closed - Deutsche Boerse AG
Other stock markets
 02:06:50 2024-05-31 EDT 		5-day change 1st Jan Change
1.447 EUR -1.30% Intraday chart for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. -0.89% -24.46%
05-27 Shanghai Fosun Pharmaceutical (Group)'s Investigational New Drug Application Accepted by NMPA MT
05-15 Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment MT

Evolution of the average Target Price on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

7c3a08110f6b61a4abf732073fc4ee.HaEU1rPT2h7dD-M2kC8NRcqvxPJtjNdac3WG5xY4yRA.U5dWlea87FrwYrB8wUZSdfnKo7Qh2JR3RgzEkX9qnmdJlnm72KCgR4t90w~273525cf4e3fbeffa3cb214d8c5ee772

Analyst Recommendations on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical : Fosun Pharma’s MSCI ESG Rating Upgraded to A PU
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
23.17 CNY
Average target price
28.61 CNY
Spread / Average Target
+23.46%
High Price Target
35 CNY
Spread / Highest target
+51.06%
Low Price Target
24.5 CNY
Spread / Lowest Target
+5.74%

Consensus detail

Consensus revision (last 18 months)

Ratings for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 600196 Stock
  4. 08HH Stock
  5. Consensus Shanghai Fosun Pharmaceutical (Group) Co., Ltd.